FTC Files Amicus Brief Explaining That "No-AG" Agreements Are Used by Drug Companies to Delay Generic Competition
Date
The Federal Trade Commission filed an amicus brief before the U.S. District Court for the District of New Jersey explaining that an agreement by a branded company not to launch an authorized generic...